![Peter DiLaura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter DiLaura
Directeur Général chez
Initial Therapeutics Inc
Profil
Peter DiLaura is currently the President, Chief Executive Officer & Director at Initial Therapeutics Inc. He is also a Director at Character Biosciences, Inc., an Executive-in-Residence at ShangPharma Innovation, Inc., and a Venture Partner at Lifeforce Capital Management, LLC.
In the past, Mr. DiLaura served as the President, Chief Executive Officer & Director at Second Genome, Inc. from 2012 to 2016.
He was also the Director of Business Development at Ventro Corp.
from 1999 to 2001.
Additionally, he held a position in business development at International Business Machines Corp.
Mr. DiLaura was a Strategic Advisor at SV Health Investors LLP from 2017 to 2019.
He was the Senior Vice President of Products & Marketing at Ingenuity Systems, Inc. in 2010.
He also served as an Advisor at Takeda Pharmaceutical Co., Ltd. in 2017.
Furthermore, Mr. DiLaura worked as a Principal at Wilkerson Group and as the Chief Business & Strategy Officer at Sonoma Biotherapeutics, Inc. Mr. DiLaura completed his undergraduate degree at the University of Pennsylvania in 1995.
He also received an undergraduate degree from The Wharton School of the University of Pennsylvania in the same year.
Postes actifs de Peter DiLaura
| Sociétés | Poste | Début |
|---|---|---|
Lifeforce Capital Management, LLC
 Lifeforce Capital Management, LLC Investment ManagersFinance Lifeforce Capital invests in companies located in the United States. The firm targets companies operating in the fields of software and healthcare sectors. It provides financing for early stage capital requirements. | Private Equity Investor | - |
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Consultant / Advisor | - |
Character Biosciences, Inc.
 Character Biosciences, Inc. BiotechnologyHealth Technology Develops precision medicine designed to transform drug development for progressive, polygenic diseases | Directeur/Membre du Conseil | - |
Initial Therapeutics Inc
 Initial Therapeutics Inc BiotechnologyHealth Technology Develops biotechnology products | Directeur Général | 18/04/2024 |
Anciens postes connus de Peter DiLaura
| Sociétés | Poste | Fin |
|---|---|---|
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Consultant / Advisor | 31/12/2019 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Consultant / Advisor | 31/12/2017 |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Directeur Général | 13/04/2016 |
Ingenuity Systems, Inc.
 Ingenuity Systems, Inc. Information Technology ServicesTechnology Services Provides information solutions for life science researchers | Sales & Marketing | 31/10/2010 |
Ventro Corp.
 Ventro Corp. Information Technology ServicesTechnology Services Provides e-commerce solutions. | Corporate Officer/Principal | 30/09/2001 |
Formation de Peter DiLaura
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
International Business Machines Corp.
 International Business Machines Corp. Information Technology ServicesTechnology Services Provides software, IT consulting, cloud and infrastructure services | Technology Services |
Ventro Corp.
Ventro Corp. Information Technology ServicesTechnology Services Provides e-commerce solutions. | Technology Services |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Ingenuity Systems, Inc.
Ingenuity Systems, Inc. Information Technology ServicesTechnology Services Provides information solutions for life science researchers | Technology Services |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Wilkerson Group
 Wilkerson Group Medical/Nursing ServicesHealth Services Consulting services to pharmaceutical and medical products industry | Health Services |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Finance |
Lifeforce Capital Management, LLC
Lifeforce Capital Management, LLC Investment ManagersFinance Lifeforce Capital invests in companies located in the United States. The firm targets companies operating in the fields of software and healthcare sectors. It provides financing for early stage capital requirements. | Finance |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
Character Biosciences, Inc.
Character Biosciences, Inc. BiotechnologyHealth Technology Develops precision medicine designed to transform drug development for progressive, polygenic diseases | Health Technology |
Initial Therapeutics Inc
Initial Therapeutics Inc BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Choisissez Zonebourse 
